Boston Financial Statements From 2010 to 2026

Stocks . USA . 
Stock . Boston Scientific Corp
BSX Stock  USD 93.79  0.18  0.19%   
Boston Scientific's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Boston Scientific's valuation are provided below:
Gross Profit
13.2 B
Profit Margin
0.1443
Market Capitalization
139.1 B
Enterprise Value Revenue
7.7315
Revenue
19.3 B
We have found one hundred twenty available fundamental signals for Boston Scientific Corp, which can be analyzed and compared to other ratios and to its rivals. All investors should make sure to validate all of Boston Scientific Corp prevailing market performance against the performance between 2010 and 2026 to make sure the company can sustain itself down the road. Market Cap is likely to rise to about 124.2 B in 2026. Enterprise Value is likely to rise to about 64.2 B in 2026

Boston Scientific Total Revenue

20.22 Billion

Check Boston Scientific financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Boston Scientific's main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.5 B, Interest Expense of 467.3 M or Selling General Administrative of 7.2 B, as well as many indicators such as Price To Sales Ratio of 4.7, Dividend Yield of 4.0E-4 or PTB Ratio of 5.9. Boston financial statements analysis is a perfect complement when working with Boston Scientific Valuation or Volatility modules.
  
Build AI portfolio with Boston Stock
Check out the analysis of Boston Scientific Correlation against competitors.

Boston Scientific Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets47.6 B45.3 B26 B
Slightly volatile
Short and Long Term Debt Total13.5 B12.8 B7.4 B
Slightly volatile
Other Current Liabilities3.7 B3.5 B2.4 B
Slightly volatile
Total Current Liabilities7.7 B7.4 B4 B
Slightly volatile
Total Stockholder Equity26.3 B25 B12.7 B
Slightly volatile
Property Plant And Equipment Net4.5 B4.3 B2.3 B
Slightly volatile
Net Debt13 B12.3 B6.9 B
Slightly volatile
Accounts Payable1.2 B1.1 B550.6 M
Slightly volatile
Cash582.1 M476.1 M545.5 M
Slightly volatile
Non Current Assets Total39.2 B37.3 B21.3 B
Slightly volatile
Non Currrent Assets Other904.4 M861.4 M583.8 M
Slightly volatile
Cash And Short Term Investments594 M476.1 M546.2 M
Slightly volatile
Net Receivables3.1 B2.9 B1.7 B
Slightly volatile
Common Stock Shares Outstanding1.2 B1.7 B1.4 B
Slightly volatile
Liabilities And Stockholders Equity47.6 B45.3 B26 B
Slightly volatile
Non Current Liabilities Total6.4 B12.6 B8.8 B
Slightly volatile
Inventory3.4 B3.2 B1.5 B
Slightly volatile
Other Current Assets792.7 M1.3 B928.7 M
Slightly volatile
Other Stockholder Equity22.7 B21.6 B16.1 B
Slightly volatile
Total Liabilities21 B20 B13.2 B
Slightly volatile
Property Plant And Equipment Gross8.8 B8.4 B3.2 B
Slightly volatile
Total Current Assets8.4 B8 B4.7 B
Slightly volatile
Short Term Debt2.1 B2 B750 M
Slightly volatile
Intangible Assets4.5 B7.7 B5.8 B
Slightly volatile
Common Stock Total Equity14.1 M19.6 M15.6 M
Slightly volatile
Common Stock14.6 M19.6 M15.8 M
Slightly volatile
Other Liabilities1.9 B2.1 B2.2 B
Very volatile
Long Term Debt5.7 B10.2 B6.2 B
Slightly volatile
Good Will20.6 B19.7 B10.2 B
Slightly volatile
Property Plant Equipment4.5 B4.3 B2.3 B
Slightly volatile
Current Deferred Revenue329.4 M275.4 M295.5 M
Slightly volatile
Long Term Debt Total7 B10.3 B6.6 B
Slightly volatile
Capital Surpluse19.8 B24.2 B18.5 B
Slightly volatile
Non Current Liabilities Other542.1 M570.6 M1.9 B
Slightly volatile
Long Term Investments473.9 M638.2 M344.4 M
Slightly volatile
Short and Long Term Debt2.1 B2 B843.9 M
Slightly volatile
Cash And Equivalents808.3 M476.1 M533.7 M
Slightly volatile
Capital Lease Obligations325.3 M606 M194.4 M
Slightly volatile
Net Invested Capital26.1 B37.2 B20.1 B
Slightly volatile
Capital Stock18.4 M19.6 M16.6 M
Slightly volatile

Boston Scientific Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization1.5 B1.5 B938.7 M
Slightly volatile
Selling General Administrative7.2 B6.9 B3.8 B
Slightly volatile
Total Revenue20.2 B19.3 B10.6 B
Slightly volatile
Gross Profit12.4 B11.8 B6.6 B
Slightly volatile
Other Operating Expenses17 B16.2 B9 B
Slightly volatile
Operating Income3.2 B3 B1.5 B
Slightly volatile
Cost Of Revenue7.8 B7.5 B4 B
Slightly volatile
Total Operating Expenses9.2 B8.8 B5 B
Slightly volatile
Research Development2 B1.9 B1.1 B
Slightly volatile
Selling And Marketing Expenses180.8 M203.4 M222 M
Slightly volatile
Non Recurring321.5 M338.4 M875.6 M
Slightly volatile
Interest Income181.8 M123 M206.1 M
Slightly volatile
Reconciled Depreciation1.1 B1.5 B959.4 M
Slightly volatile

Boston Scientific Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow667 M1.2 B760.3 M
Slightly volatile
Depreciation1.5 B1.5 B938.8 M
Slightly volatile
Capital Expenditures953.9 M908.5 M456.2 M
Slightly volatile
Total Cash From Operating Activities4.1 B4 B1.7 B
Slightly volatile
End Period Cash Flow671.6 M696.9 M735.9 M
Slightly volatile
Stock Based Compensation224.8 M239.4 M157.3 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio4.79.034.5973
Slightly volatile
Dividend Yield4.0E-44.0E-40.0011
Slightly volatile
PTB Ratio5.96.944.8291
Very volatile
Days Sales Outstanding67.3964.1161.0375
Slightly volatile
Book Value Per Share14.1313.468.5052
Slightly volatile
Operating Cash Flow Per Share2.212.11.116
Slightly volatile
Stock Based Compensation To Revenue0.01730.01830.0156
Slightly volatile
Capex To Depreciation0.680.720.568
Pretty Stable
PB Ratio5.96.944.8291
Very volatile
EV To Sales5.29.765.2069
Slightly volatile
ROIC0.10.07050.0727
Slightly volatile
Inventory Turnover2.262.082.6961
Slightly volatile
Days Of Inventory On Hand154182138
Slightly volatile
Payables Turnover11.627.769.0188
Slightly volatile
Sales General And Administrative To Revenue0.40.390.3438
Slightly volatile
Research And Ddevelopement To Revenue0.130.110.109
Pretty Stable
Capex To Revenue0.08390.05420.0432
Slightly volatile
Cash Per Share0.360.250.3789
Slightly volatile
POCF Ratio47.9444.038.6967
Pretty Stable
Interest Coverage6.87.836.3526
Pretty Stable
Capex To Operating Cash Flow0.250.260.321
Very volatile
Days Payables Outstanding35.1448.6744.8323
Slightly volatile
EV To Operating Cash Flow52.4547.643.9693
Pretty Stable
Intangibles To Total Assets0.410.540.5918
Pretty Stable
Current Ratio1.91.241.484
Slightly volatile
Receivables Turnover4.825.895.9837
Pretty Stable
Graham Number19.3518.4311.4001
Slightly volatile
Shareholders Equity Per Share13.9813.318.4682
Slightly volatile
Debt To Equity0.470.460.6031
Very volatile
Capex Per Share0.250.480.2892
Slightly volatile
Revenue Per Share10.7510.247.1376
Slightly volatile
Interest Debt Per Share7.417.055.2206
Slightly volatile
Debt To Assets0.210.250.2718
Slightly volatile
Short Term Coverage Ratios1.651.7472.1297
Slightly volatile
Operating Cycle221246199
Slightly volatile
Price Book Value Ratio5.96.944.8291
Very volatile
Days Of Payables Outstanding35.1448.6744.8323
Slightly volatile
Price To Operating Cash Flows Ratio47.9444.038.6967
Pretty Stable
Operating Profit Margin0.20.180.1554
Very volatile
Company Equity Multiplier1.661.632.1477
Slightly volatile
Long Term Debt To Capitalization0.220.260.3376
Pretty Stable
Total Debt To Capitalization0.270.30.3658
Pretty Stable
Return On Capital Employed0.180.09180.1103
Slightly volatile
Debt Equity Ratio0.470.460.6031
Very volatile
Ebit Per Revenue0.20.180.1554
Very volatile
Quick Ratio1.410.741.0181
Slightly volatile
Dividend Paid And Capex Coverage Ratio2.773.913.5207
Slightly volatile
Net Income Per E B T0.70.731.1287
Very volatile
Cash Ratio0.07070.07440.1598
Very volatile
Cash Conversion Cycle173184153
Very volatile
Operating Cash Flow Sales Ratio0.170.240.1491
Slightly volatile
Days Of Inventory Outstanding154182138
Slightly volatile
Days Of Sales Outstanding67.3964.1161.0375
Slightly volatile
Cash Flow Coverage Ratios0.50.350.292
Pretty Stable
Price To Book Ratio5.96.944.8291
Very volatile
Fixed Asset Turnover5.295.144.8923
Slightly volatile
Capital Expenditure Coverage Ratio2.863.913.5786
Pretty Stable
Price Cash Flow Ratio47.9444.038.6967
Pretty Stable
Debt Ratio0.210.250.2718
Slightly volatile
Cash Flow To Debt Ratio0.50.350.292
Pretty Stable
Price Sales Ratio4.79.034.5973
Slightly volatile
Asset Turnover0.670.490.5036
Slightly volatile
Gross Profit Margin0.730.710.6369
Slightly volatile
Price Fair Value5.96.944.8291
Very volatile

Boston Scientific Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap124.2 B118.3 B57.2 B
Slightly volatile
Enterprise Value64.2 B61.2 B49 B
Slightly volatile

Boston Fundamental Market Drivers

Forward Price Earnings26.9542
Cash And Short Term Investments414 M

Boston Upcoming Events

31st of January 2024
Upcoming Quarterly Report
View
24th of April 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
31st of January 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Boston Scientific Financial Statements

Boston Scientific investors use historical fundamental indicators, such as Boston Scientific's revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Boston Scientific. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue275.4 M329.4 M
Total Revenue19.3 B20.2 B
Cost Of Revenue7.5 B7.8 B
Stock Based Compensation To Revenue 0.02  0.02 
Sales General And Administrative To Revenue 0.39  0.40 
Research And Ddevelopement To Revenue 0.11  0.13 
Capex To Revenue 0.05  0.08 
Revenue Per Share 10.24  10.75 
Ebit Per Revenue 0.18  0.20 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
VTIVanguard Total Stock
RIOTRiot Blockchain
TSLATesla Inc

Additional Tools for Boston Stock Analysis

When running Boston Scientific's price analysis, check to measure Boston Scientific's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Boston Scientific is operating at the current time. Most of Boston Scientific's value examination focuses on studying past and present price action to predict the probability of Boston Scientific's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Boston Scientific's price. Additionally, you may evaluate how the addition of Boston Scientific to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY